• By:admin

Does Testosterone Replacement Therapy Really Work?

Testosterone therapy is used to boost testosterone in men with decreasing levels, but there is now evidence the prescription products do little to improve ejaculatory function, as claimed. There are also allegations against the manufacturers of these products claiming cardiovascular health problems were triggered by their use of synthetic testosterone products, and despite knowing of these risks, the manufacturers failed to issue any warning.

The most current information regarding the effectiveness of testosterone products was published in the Journal of Clinical Endocrinology & Metabolism in July 2015. The study showed men with symptoms of low testosterone related to aging and not medical conditions experienced no sexual function improvements as a result of using the drugs. Researchers admitted follow-up studies are needed to validate conclusions, but encouraged doctors treating patients for sexual disorders to look at potential causes other than testosterone levels.

The new information comes on the heels of a March 2015 Safety Announcement issued by the FDA regarding the use of testosterone replacement products. The agency cautioned that testosterone therapy be used only in cases where men lack or have low testosterone levels due to a medical condition. In the announcement, the FDA stated “… the benefit and safety of these medications have not been established for the treatment of low testosterone levels due to aging, even if a man’s symptoms seem related to low testosterone.”

An FDA Advisory Committee concluded in 2014 that testosterone use creates an increased risk for cardiovascular complications. The committee requested information be added to drug labels to make clear the approved uses of the product, as well as the potential risks.

Concerns Mount over Prescription Testosterone and Marketing Claims

There are many different prescription testosterone products available and most are marketed to treat a condition known as Low-T. Debate rages over whether or not the products do anything at all to help with Low-T (and some argue Low-T is not really a medical condition).

There is also another factor involved in the testosterone product discussion: direct-to-consumer marketing. Many drug manufacturers market directly to consumers, in addition to doctors, but few products have been as aggressive with this type of campaign as testosterone. Manufacturers promise youth, vitality, increased strength and sex drive, but mention the side effects only in passing, if at all.

One of the biggest concerns about testosterone products is the trick drug marketers use to reach a new audience. They “piggyback” claims about their product onto existing FDA approvals. This means a product is approved by the FDA for one use, but the drug is marketed as effective for treating three or four different issues.

For instance, in addition to treating a decrease in testosterone levels due to a medical disorder, testosterone products are marketed as effective for boosting naturally decreasing testosterone levels due to age and claiming to help with the general effects of aging overall. Many of the testosterone drugs on the market claim to “improve youth and vitality,” without ever stating specifically what that means.

If you have used a testosterone product and experienced negative side effects – or experienced nothing at all – you should speak to your doctor.

Related Post

VIEW all
Teva, Major Pharmacies Found Liable for Actions in Opioid Crisis in New York, Ohio
  • By:B. Shaffer

Pharmaceutical manufacturing giant, Teva has been found guilty of its role in the opioid crisis in the state of New York. In a separate ruling in Ohio, major pharmacies Walgreens, CVS and Walmart have been found liable for helping to create an oversupply of drugs leading to the opioid epidemic. The findings are in addition to others reached in federal and other state courts. Teva Found Guilty in State of New York Opioid Crisis A New York jury has ruled …

Opioid Epidemic
Judge Rejects Opioid Lawsuit Settlement for Purdue Pharma’s Sackler Family
  • By:B. Shaffer

A federal judge has rejected Purdue Pharma’s Opioid Lawsuit Settlement agreement releasing the Sackler Family from liability over OxyContin. The agreement had been reached on December 16, 2021, in bankruptcy court and would settle thousands of Opioid lawsuits filed by government agencies and people who had been harmed by OxyContin. Through the bankruptcy court agreement, the Sackler family was to be allowed to pay $4.5 billion to avoid civil liability over their involvement in the Purdue Pharma-OxyContin Opioid lawsuit battles. …

weight loss drug
Weight Loss Drug Removed from Market after Cancer Linked Identified
  • By:B. Shaffer

Eisai, Inc. voluntarily pulled its weight-loss drug Belviq from the market in February 2020 after it was determined that the drug poses a slightly increased risk of cancer. Despite the recall of the product, Eisai said it did not believe the FDA’s interpretation of the latest round of data on the drug’s safety and stated that it still believes the benefits outweigh the risks. According to the FDA, patients currently using Belviq should stop doing so immediately. They should dispose …

Have you been affected by a drug or device listed?